Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1998 1
1999 3
2000 4
2001 7
2002 7
2003 8
2004 10
2005 12
2006 11
2007 14
2008 8
2009 7
2010 5
2011 9
2012 12
2013 18
2014 19
2015 12
2016 12
2017 10
2018 10
2019 11
2020 8
2021 18
2022 15
2023 19
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

242 results

Results by year

Filters applied: . Clear all
Page 1
Statins as antithrombotic drugs.
Violi F, Calvieri C, Ferro D, Pignatelli P. Violi F, et al. Circulation. 2013 Jan 15;127(2):251-7. doi: 10.1161/CIRCULATIONAHA.112.145334. Circulation. 2013. PMID: 23319813 Review. No abstract available.
Effects of statins on mitochondrial pathways.
Mollazadeh H, Tavana E, Fanni G, Bo S, Banach M, Pirro M, von Haehling S, Jamialahmadi T, Sahebkar A. Mollazadeh H, et al. J Cachexia Sarcopenia Muscle. 2021 Apr;12(2):237-251. doi: 10.1002/jcsm.12654. Epub 2021 Jan 29. J Cachexia Sarcopenia Muscle. 2021. PMID: 33511728 Free PMC article. Review.
Statins are a family of drugs that are used for treating hyperlipidaemia with a recognized capacity to prevent cardiovascular disease events. ...Despite all beneficial effects, statins may elicit adverse reactions such as myopathy. Studies have shown that mit …
Statins are a family of drugs that are used for treating hyperlipidaemia with a recognized capacity to prevent cardiovascular …
Contemporary Medical Management of Peripheral Artery Disease.
Bonaca MP, Hamburg NM, Creager MA. Bonaca MP, et al. Circ Res. 2021 Jun 11;128(12):1868-1884. doi: 10.1161/CIRCRESAHA.121.318258. Epub 2021 Jun 10. Circ Res. 2021. PMID: 34110910 Review.
Treatment with guideline-recommended therapies, including smoking cessation, lipid lowering drugs, optimal glucose control, and antithrombotic medications lowers the incidence of major adverse cardiovascular events and major adverse limb events. ...
Treatment with guideline-recommended therapies, including smoking cessation, lipid lowering drugs, optimal glucose control, and an …
Statins as an adjunctive therapy for COVID-19: the biological and clinical plausibility.
Kashour T, Halwani R, Arabi YM, Sohail MR, O'Horo JC, Badley AD, Tleyjeh IM. Kashour T, et al. Immunopharmacol Immunotoxicol. 2021 Feb;43(1):37-50. doi: 10.1080/08923973.2020.1863984. Epub 2021 Jan 6. Immunopharmacol Immunotoxicol. 2021. PMID: 33406943 Review.
These beneficial properties of statins are a result of their multiple pleotropic effects that include, anti-inflammatory, immunomodulatory, antithrombotic and antimicrobial properties. In this review, we provide a comprehensive description of the mechanisms of the p …
These beneficial properties of statins are a result of their multiple pleotropic effects that include, anti-inflammatory, immunomodul …
Statins as regulators of redox signaling in platelets.
Violi F, Pignatelli P. Violi F, et al. Antioxid Redox Signal. 2014 Mar 10;20(8):1300-12. doi: 10.1089/ars.2013.5527. Epub 2013 Oct 4. Antioxid Redox Signal. 2014. PMID: 23992095 Review.
CRITICAL ISSUES: Experimental and clinical studies documented that statins possess an antithrombotic effects which may account for thrombotic-related vascular outcomes. This has been evidenced in clinical settings such as percutaneous coronary intervention, myocardi …
CRITICAL ISSUES: Experimental and clinical studies documented that statins possess an antithrombotic effects which may account …
Emerging agents for the treatment and prevention of stroke: progress in clinical trials.
Safouris A, Magoufis G, Tsivgoulis G. Safouris A, et al. Expert Opin Investig Drugs. 2021 Oct;30(10):1025-1035. doi: 10.1080/13543784.2021.1985463. Epub 2021 Oct 13. Expert Opin Investig Drugs. 2021. PMID: 34555978 Review.
Novel approaches are being tested to enhance the efficacy of thrombolysis or provide neuroprotection in non-thrombolized patients. AREAS COVERED: The current review highlights pharmaceutical agents under evaluation in clinical trials concerning the acute, subacute, and chr …
Novel approaches are being tested to enhance the efficacy of thrombolysis or provide neuroprotection in non-thrombolized patients. AREAS COV …
Pharmacogenetics of antithrombotic drugs.
Tàssies D. Tàssies D. Curr Pharm Des. 2006;12(19):2425-35. doi: 10.2174/138161206777698963. Curr Pharm Des. 2006. PMID: 16842189 Review.
However, there is substantial interindividual variability in the response to antithrombotic drugs. This variability is due, in part, to genetics, which may affect the efficacy and safety of drugs used in the treatment and prevention of thrombosis. ...There is …
However, there is substantial interindividual variability in the response to antithrombotic drugs. This variability is due, in …
Cardiovascular Disease.
Walden R, Tomlinson B. Walden R, et al. In: Benzie IFF, Wachtel-Galor S, editors. Herbal Medicine: Biomolecular and Clinical Aspects. 2nd edition. Boca Raton (FL): CRC Press/Taylor & Francis; 2011. Chapter 16. In: Benzie IFF, Wachtel-Galor S, editors. Herbal Medicine: Biomolecular and Clinical Aspects. 2nd edition. Boca Raton (FL): CRC Press/Taylor & Francis; 2011. Chapter 16. PMID: 22593934 Free Books & Documents. Review.
There is extensive evidence to show that drug treatment of conventional risk factors is effective in reducing cardiovascular events. Many large clinical trials with the HMG CoA reductase inhibitors (statins) have showed that lowering of LDL cholesterol with t …
There is extensive evidence to show that drug treatment of conventional risk factors is effective in reducing cardiovascular events. Many la …
The statins: multifunctional antithrombotic and antineoplastic drugs.
Splichal JE, Stamm JA, Ornstein DL. Splichal JE, et al. Semin Thromb Hemost. 2003 Jun;29(3):259-74. doi: 10.1055/s-2003-40964. Semin Thromb Hemost. 2003. PMID: 12888930 Review.
The versatility of statins is increasingly being appreciated, however, and lowering cholesterol is only one attribute among many shared by this class of drugs. Most statins appear to have antithrombotic activity that is unrelated to the ability to redu …
The versatility of statins is increasingly being appreciated, however, and lowering cholesterol is only one attribute among many shar …
Nanoparticle Therapy for Vascular Diseases.
Flores AM, Ye J, Jarr KU, Hosseini-Nassab N, Smith BR, Leeper NJ. Flores AM, et al. Arterioscler Thromb Vasc Biol. 2019 Apr;39(4):635-646. doi: 10.1161/ATVBAHA.118.311569. Arterioscler Thromb Vasc Biol. 2019. PMID: 30786744 Free PMC article. Review.
Systemic exposure and drug-drug interactions remain a concern for nearly all cardiovascular therapies, including statins, antithrombotic, and thrombolytic agents. Moreover, off-target effects and poor bioavailability have limited the development of completely new ap …
Systemic exposure and drug-drug interactions remain a concern for nearly all cardiovascular therapies, including statins, antithro …
242 results